文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

救护车院前抗生素治疗脓毒症:一项多中心、开放标签、随机试验

Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial.
PubMed 文献 · Lancet Respir Med · 2017-11-28
一句话结论在救护车中早期给予头孢曲松并未改善脓毒症患者28天生存率(RR 0.95,95%CI 0.74-1.24),但急救人员培训改善了早期识别和整个急救链的早期治疗。

该多中心开放标签随机试验在荷兰10个大型区域救护车服务机构(服务34家二级和三级医院)中,比较了急救人员在救护车中早期给予头孢曲松2000 mg静脉注射联合常规治疗与仅常规治疗(液体复苏和补充氧)对脓毒症患者的效果。共纳入2698例患者,2672例纳入意向性分析(干预组1535例,常规组1137例)。干预组在到达急诊科前中位26分钟接受抗生素;28天全因死亡率干预组8%(120例)vs 常规组8%(93例),相对风险0.95(95%CI 0.74-1.24)。干预组28天内再入院7%(102例)vs 常规组10%(119例)(p=0.0004)。结论:急救人员培训改善了早期识别和整个急救链的早期治疗,但救护车中给予抗生素并未改善生存率,无论病情严重程度如何。

要点

  • 在救护车中由急救人员给予头孢曲松2000 mg静脉注射并未改善脓毒症患者28天生存率:干预组8%(120例)vs 常规组8%(93例),RR 0.95(95%CI 0.74-1.24)。
  • 急救人员培训后,常规组到达急诊科后中位抗生素时间70分钟(IQR 36-128),培训前为93分钟(IQR 39-140)(p=0.142)。
  • 干预组在到达急诊科前中位26分钟(IQR 19-34)接受抗生素。
  • 干预组28天内再入院7%(102例)vs 常规组10%(119例)(p=0.0004)。
  • 发生7例轻度过敏反应,均不能归因于头孢曲松。

适用人群与场景

  • 荷兰10个大型区域救护车服务机构中,由急救人员识别为脓毒症的患者,服务于34家二级和三级医院。
  • 纳入不同严重程度的脓毒症患者。

处置流程与药物剂量

  • 干预组:在救护车中由急救人员给予开放标签头孢曲松2000 mg静脉注射,并联合常规治疗。
  • 常规组:液体复苏和补充氧。
  • 急救人员接受脓毒症识别培训。

研究设计与关键结果

  • 多中心、开放标签、随机对照试验,纳入2698例患者,2672例纳入意向性分析(干预组1535例,常规组1137例),随机化按区域分层,采用区组大小为4的区组随机化。
  • 主要终点28天全因死亡率:干预组8%(120例)vs 常规组8%(93例),相对风险0.95(95%CI 0.74-1.24)。
  • 干预组在到达急诊科前中位26分钟(IQR 19-34)接受抗生素;常规组到达急诊科后中位抗生素时间70分钟(IQR 36-128),培训前为93分钟(IQR 39-140)(p=0.142)。
  • 28天内再入院:干预组7%(102例)vs 常规组10%(119例)(p=0.0004)。
  • 发生7例轻度过敏反应,均不能归因于头孢曲松。

证据类型、等级与局限

  • 证据类型:多中心、开放标签、随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,对病情严重程度不同的脓毒症患者,急救人员培训改善了早期识别和整个急救链的早期治疗。
  • 作者认为,在救护车中给予抗生素并未改善生存率,无论病情严重程度如何。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Emergency medical services (EMS) personnel have already made substantial contributions to improving care for patients with time-dependent illnesses, such as trauma and myocardial infarction. Patients with sepsis could also benefit from timely prehospital care.

METHODS: After training EMS personnel in recognising sepsis, we did a randomised controlled open-label trial in ten large regional ambulance services serving 34 secondary and tertiary care hospitals in the Netherlands. We compared the effects of early administration of antibiotics in the ambulance with usual care. Eligible patients were randomly assigned (1:1) using block-randomisation with blocks of size 4 to the intervention (open-label intravenous ceftriaxone 2000 mg in addition to usual care) or usual care (fluid resuscitation and supplementary oxygen). Randomisation was stratified per region. The primary outcome was all-cause mortality at 28 days and analysis was by intention to treat. To assess the effect of training, we determined the average time to antibiotics (TTA) in the emergency department and recognition of sepsis by EMS personnel before and after training. The trial is registered at ClinicalTrials.gov, number NCT01988428.

FINDINGS: 2698 patients were enrolled between June 30, 2014, and June 26, 2016. 2672 patients were included in the intention-to-treat analysis: 1535 in the intervention group and 1137 in the usual care group. The intervention group received antibiotics a median of 26 min (IQR 19-34) before arriving at the emergency department. In the usual care group, median TTA after arriving at the emergency department was 70 min (IQR 36-128), compared with 93 min (IQR 39-140) before EMS personnel training (p=0·142). At day 28, 120 (8%) patients had died in the intervention group and 93 (8%) had died in the usual care group (relative risk 0·95, 95% CI 0·74-1·24). 102 (7%) patients in the intervention group and 119 (10%) in the usual care group were re-admitted to hospital within 28 days (p=0·0004). Seven mild allergic reactions occurred, none of which could be attributed to ceftriaxone.

INTERPRETATION: In patients with varying severity of sepsis, EMS personnel training improved early recognition and care in the whole acute care chain. However, giving antibiotics in the ambulance did not lead to improved survival, regardless of illness severity.

FUNDING: The NutsOhra Foundation, Netherlands Society of Internal Medicine (NIV).

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Alam N, Oskam E, Stassen PM, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2017. PMID: 29196046. doi:10.1016/S2213-2600(17)30469-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。